First Midwest Bank Trust Division’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-809
| Closed | -$229K | – | 378 |
|
|
2021
Q3 | $229K | Sell |
809
-36
| -4% | -$11.8K | 0.03% | 342 |
|
|
2021
Q2 | $293K | Sell |
845
-303
| -26% | -$91.8K | 0.04% | 327 |
|
|
2021
Q1 | $322K | Sell |
1,148
-126
| -10% | -$34K | 0.04% | 313 |
|
|
2020
Q4 | $312K | Sell |
1,274
-120
| -9% | -$31K | 0.05% | 298 |
|
|
2020
Q3 | $396K | Sell |
1,394
-25
| -2% | -$6.97K | 0.06% | 263 |
|
|
2020
Q2 | $380K | Sell |
1,419
-50
| -3% | -$15K | 0.06% | 268 |
|
|
2020
Q1 | $465K | Sell |
1,469
-63
| -4% | -$19.1K | 0.08% | 225 |
|
|
2019
Q4 | $455K | Sell |
1,532
-46
| -3% | -$12.8K | 0.06% | 264 |
|
|
2019
Q3 | $368K | Sell |
1,578
-25
| -2% | -$5.82K | 0.05% | 293 |
|
|
2019
Q2 | $375K | Sell |
1,603
-488
| -23% | -$113K | 0.05% | 301 |
|
|
2019
Q1 | $494K | Sell |
2,091
-109
| -5% | -$34.3K | 0.07% | 272 |
|
|
2018
Q4 | $662K | Sell |
2,200
-3,260
| -60% | -$1.04M | 0.1% | 205 |
|
|
2018
Q3 | $1.93M | Buy |
5,460
+57
| +1% | +$19.6K | 0.26% | 100 |
|
|
2018
Q2 | $1.57M | Sell |
5,403
-665
| -11% | -$187K | 0.22% | 123 |
|
|
2018
Q1 | $1.66M | Sell |
6,068
-435
| -7% | -$135K | 0.23% | 124 |
|
|
2017
Q4 | $2.07M | Buy |
6,503
+3,665
| +129% | +$1.18M | 0.26% | 110 |
|
|
2017
Q3 | $889K | Sell |
2,838
-228
| -7% | -$67.5K | 0.11% | 226 |
|
|
2017
Q2 | $832K | Sell |
3,066
-120
| -4% | -$31.7K | 0.1% | 239 |
|
|
2017
Q1 | $871K | Sell |
3,186
-4,056
| -56% | -$1.15M | 0.11% | 242 |
|
|
2016
Q4 | $2.05M | Sell |
7,242
-35
| -0.5% | -$10.4K | 0.25% | 117 |
|
|
2016
Q3 | $2.28M | Buy |
7,277
+3,914
| +116% | +$1.16M | 0.28% | 100 |
|
|
2016
Q2 | $813K | Buy |
3,363
+166
| +5% | +$43.7K | 0.1% | 227 |
|
|
2016
Q1 | $832K | Sell |
3,197
-325
| -9% | -$85.8K | 0.11% | 198 |
|
|
2015
Q4 | $1.08M | Sell |
3,522
-427
| -11% | -$123K | 0.18% | 135 |
|
|
2015
Q3 | $1.15M | Sell |
3,949
-4,435
| -53% | -$1.46M | 0.2% | 129 |
|
|
2015
Q2 | $3.39M | Sell |
8,384
-106
| -1% | -$42.5K | 0.54% | 42 |
|
|
2015
Q1 | $3.58M | Sell |
8,490
-2,716
| -24% | -$1.07M | 0.55% | 39 |
|
|
2014
Q4 | $3.8M | Sell |
11,206
-571
| -5% | -$185K | 0.59% | 37 |
|
|
2014
Q3 | $3.9M | Buy |
11,777
+88
| +0.8% | +$29K | 0.63% | 34 |
|
|
2014
Q2 | $3.69M | Sell |
11,689
-680
| -5% | -$205K | 0.58% | 34 |
|
|
2014
Q1 | $3.78M | Sell |
12,369
-355
| -3% | -$113K | 0.62% | 32 |
|
|
2013
Q4 | $3.56M | Sell |
12,724
-271
| -2% | -$70.1K | 0.62% | 31 |
|
|
2013
Q3 | $3.13M | Sell |
12,995
-240
| -2% | -$53.7K | 0.62% | 34 |
|
|
2013
Q2 | $2.85M | Buy |
+13,235
| New | +$2.83M | 0.57% | 45 |
|
Other funds holding BIIB
First Midwest Bank Trust Division's BIIB Position: Q4 2021 in Review
First Midwest Bank Trust Division sold out of Biogen (BIIB) in Q4 2021, closing a stake of 809 shares — an estimated $229K sold.
First Midwest Bank Trust Division first reported a position in BIIB in Q2 2013 and held it in 34 quarters. The position peaked at $3.9M in Q3 2014. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.
- First Midwest Bank Trust Division reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
- First Midwest Bank Trust Division sold 809 Biogen shares in Q4 2021, an estimated $229K.
- First Midwest Bank Trust Division first reported a position in Biogen in Q2 2013 and held it in 34 quarters.
- First Midwest Bank Trust Division's Biogen position peaked at $3.9M in Q3 2014.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.
Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.